Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing ...

Our Bureau, Bengaluru Monday, September 29, 2025, 14:15 Hrs [IST] ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling ...

Elli Lilly has chosen a location near Richmond, VA, for its planned $5 billion manufacturing plant that will be the first-ever dedicated, fully integrated active pharmaceutical ingredient (API) and ...

The Houston facility has been selected as one that will make orforglipron, Lilly's new oral GLP-1 agonist for weight-loss, ...

The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the ...

Another multi-billion-dollar company is expanding operations in Texas after receiving millions of dollars through a new ...

The "API CDMO Service Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.The future of the global API CDMO service market looks ...

The API and drug product facility is the first of four new manufacturing plants set to be built by Eli Lilly in the US over ...

A recent executive order signed by President Donald Trump calls for the government to build a Strategic Active Pharmaceutical Ingredients Reserve ...

Mumbai: Indoco Remedies Limited has announced that the United States Food and Drug Administration (USFDA) successfully ...

The 100% tariff on imported drugs will pressure pharma companies to build manufacturing sites in the US or face significant ...